Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Apr 19;2(5963):116–118. doi: 10.1136/bmj.2.5963.116

Use of oxytocin and incidence of neonatal jaundice.

I Chalmers, H Campbell, A C Turnbull
PMCID: PMC1673078  PMID: 1125700

Abstract

A retrospective controlled study using data from the Cardiff Births Survey examined a possible relation between oxytocin administration to induce or accelerate labour and the subsequent development of neonatal jaundice. Among 10 591 infants born in Cardiff between 1970 and 1972 the incidence of neonatal jaundice was higher in infants born after oxytocin administration than among others. Analysis by gestational age at delivery, birth weight, Apgar score, length of labour, sedative and analgesic therapy during labour, and suppression of lactation showed that this association held within all these categories except among small immature infants, who are at high risk of jaundice in any case.

Full text

PDF
116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman B., Beazley J. M. Letter: Oxytocin in labour and neonatal jaundice. Br Med J. 1974 Sep 7;3(5931):624–625. doi: 10.1136/bmj.3.5931.624-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blackburn M. G., Mancusi-Ungaro H. R., Jr, Orzalesi M. M., Hobbins J. C., Anderson G. G. Effects on the neonate of the induction of labor with prostaglandin F 2 and oxytocin. Am J Obstet Gynecol. 1973 Jul 15;116(6):847–853. doi: 10.1016/0002-9378(73)91020-x. [DOI] [PubMed] [Google Scholar]
  3. Calder A. A., Ounsted M. K., Moar V. A., Turnbull A. C. Increased bilirubin levels in neonates after induction of labour by intravenous prostaglandin E2 or oxytocin. Lancet. 1974 Dec 7;2(7893):1339–1342. doi: 10.1016/s0140-6736(74)92212-0. [DOI] [PubMed] [Google Scholar]
  4. Chamberlain G. Letter: Dangers of oxytocin-induced labour to fetuses. Br Med J. 1974 Sep 14;3(5932):684–684. doi: 10.1136/bmj.3.5932.684-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davidson D. C., Ford J. A., McIntosh W. Letter: Neonatal jaundice and maternal oxytocin infusion. Br Med J. 1973 Oct 13;4(5884):106–107. doi: 10.1136/bmj.4.5884.106-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedman E. A., Sachtleben M. R. Letter: Oxytocin and neonatal jaundice. Lancet. 1974 Sep 7;2(7880):600–600. doi: 10.1016/s0140-6736(74)91931-x. [DOI] [PubMed] [Google Scholar]
  7. Ghosh A., Hudson F. P. Oxytocic agents and neonatal hyperbilirubinaemia. Lancet. 1972 Oct 14;2(7781):823–823. doi: 10.1016/s0140-6736(72)92182-4. [DOI] [PubMed] [Google Scholar]
  8. Gray H. G., Mitchell R. Letter: Neonatal hyperbilirubinaemia and oxytocin. Lancet. 1974 Nov 9;2(7889):1144–1144. doi: 10.1016/s0140-6736(74)90907-6. [DOI] [PubMed] [Google Scholar]
  9. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  10. McConnell J. B., Glasgow J. F., McNair R. Effect on neonatal jaundice of oestrogens and progestogens taken before and after conception. Br Med J. 1973 Sep 22;3(5881):605–607. doi: 10.1136/bmj.3.5881.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Quakernack K., Mast H. Der Einfluss der Whenmittel auf den Icterus neonatorum. Arch Gynakol. 1971 Jun 4;211(1):144–146. doi: 10.1007/BF00682863. [DOI] [PubMed] [Google Scholar]
  12. Roberts G., Weaver A. Letter: Labour and neonatal jaundice. Lancet. 1974 May 11;1(7863):935–935. doi: 10.1016/s0140-6736(74)90392-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES